Similar Papers

Paper Title
Journal
Date
Author
PHP250 - Evolution & Influence of HTA in Emerging Markets
C Yong ... S Duttagupta
Value in Health | VOL. 18
C Yong, et. al.C Yong ... S Duttagupta
20 Oct 2015
Drug pricing and reimbursement decision making systems in Mongolia
Gereltuya Dorj ... Tsetsegmaa Sanjjav
Journal of Pharmaceutical Policy and Practice | VOL. 10
Gereltuya Dorj, et. al.Gereltuya Dorj ... Tsetsegmaa Sanjjav
27 Feb 2017
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Xavier Badia ... José Luis Poveda-Andrés
Orphanet Journal of Rare Diseases | VOL. 15
Xavier Badia, et. al.Xavier Badia ... José Luis Poveda-Andrés
28 Aug 2020
Pricing of pharmaceuticals. Assessing the pricing potential by a pricing matrix model.
Markj.C Nuijten ... Joszef Kosa
The European Journal of Health Economics, formerly: HEPAC | VOL. 5
Markj.C Nuijten, et. al.Markj.C Nuijten ... Joszef Kosa
01 May 2004
View more papers

More From: Value in Health

Paper Title
Journal
Date
Author
Table of Contents
-
Value in Health | VOL. -
--
01 Jan 2025
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force
Siobhan Botwright ... Yot Teerawattananon
Value in Health | VOL. -
Siobhan Botwright, et. al.Siobhan Botwright ... Yot Teerawattananon
01 Jan 2025
Editorial Board
-
Value in Health | VOL. -
--
01 Jan 2025
EE334 Use of Disease Analogues to Inform Health-Economic Parameters for Economic Evaluations of Rare Diseases: A Case-Study of Multiple System Atrophy
T Grand ... Pf Krismer
Value in Health | VOL. 27
T Grand, et. al.T Grand ... Pf Krismer
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.